Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | INSM | LEGN | ||
| Company | Acceleron Pharma | Insmed Inc | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 76.54 | 59.28 | ||
| High | 179.85 | 77.40 | 60.19 | ||
| Low | 177.06 | 75.24 | 58.50 | ||
| Last | 178.75 | 76.28 | 58.93 | ||
| Change | -0.93 | +0.31 | +0.19 | ||
| % Change | -0.52% | +0.41% | +0.32% | ||
| Volume | 7,884,200 | 1,658,400 | 837,400 | ||
| 20-Day Average Volume | 1,302,050 | 2,883,700 | 1,245,160 | ||
| Previous Close | 179.68 | 75.97 | 58.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 71.47 | 49.43 | ||
| 20-Day Raw Stochastic | 84.01% | 85.07% | 93.11% | ||
| 20-Day Relative Strength | 70.12% | 72.31% | 71.29% | ||
| Weighted Alpha | +57.78 | +76.74 | -14.37 | ||
| Today's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -1.54% since 07/15/24 | +9.15% since 07/15/24 | ||
| Low | 173.17 on 11/16/21 | 73.70 on 07/18/24 | 54.27 on 07/16/24 | ||
| High | 179.94 on 11/17/21 | 78.87 on 07/16/24 | 60.19 on 07/22/24 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +12.19% since 06/21/24 | +38.30% since 06/21/24 | ||
| Low | 172.25 on 10/20/21 | 61.52 on 07/03/24 | 41.89 on 06/25/24 | ||
| High | 179.94 on 11/17/21 | 78.87 on 07/16/24 | 60.19 on 07/22/24 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +216.38% since 04/22/24 | +25.22% since 04/22/24 | ||
| Low | 120.20 on 08/20/21 | 21.92 on 05/24/24 | 38.60 on 06/03/24 | ||
| High | 189.99 on 09/29/21 | 78.87 on 07/16/24 | 60.19 on 07/22/24 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +167.37% since 01/22/24 | +4.86% since 01/22/24 | ||
| Low | 113.49 on 07/15/21 | 21.92 on 05/24/24 | 38.60 on 06/03/24 | ||
| High | 189.99 on 09/29/21 | 78.87 on 07/16/24 | 70.13 on 02/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,289,521 | 10,707,304 | ||
| Shares Outstanding, K | 61,156 | 148,605 | 182,283 | ||
| Annual Sales | 92,520,000 | 305,210,000 | 285,140,000 | ||
| Annual Net Income | -166,030,000 | -749,570,000 | -518,250,000 | ||
| Last Quarter Sales | 34,200,000 | 75,500,000 | 93,990,000 | ||
| Last Quarter Net Income | -70,470,000 | -157,090,000 | -59,790,000 | ||
| 60-Month Beta | 0.13 | 1.16 | 0.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | -1.06 on 05/09/24 | -0.16 on 05/13/24 | ||
| Latest Earnings Date | 11/04/21 | 08/01/24 | 08/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||